# Saxagliptin + Dapagliflozin

## Qtern 5/10mg

| TAH Drug Code      | [OQTE](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OQTE)                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Adults aged 18 years and older with type 2 diabetes mellitus: 1. to improve glycaemic control when metformin and one of the monocomponents of Qtern do not provide adequate glycaemic control. 2. already being treated with the free combination of dapagliflozin and saxagliptin.                                                                                                                           |
| Dosing             | 1 tablet QD. Each tablet contains saxagliptin 5mg and dapagliflozin 10mg.                                                                                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Patients with a history of severe allergic reactions to saxagliptin or dapagliflozin, including allergic reactions, angioedema, or exfoliative skin diseases. Moderate to severe renal impairment (eGFR less than 45 mL/min/1.73 m2), end-stage renal disease (ESRD), or patients on dialysis. Contraindicated in patients who are allergic to saxagliptin or dapagliflozin.                                  |
| Adverse Effects    | Common Endocrine metabolic: Hypoglycemia (1% ) Respiratory: Upper respiratory infection (13.6% ) Serious Cardiovascular: Heart failure, Hypotension Endocrine metabolic: Diabetic ketoacidosis Gastrointestinal: Pancreatitis (0.2% ) Immunologic: Hypersensitivity reaction Renal: Acute kidney injury, nontraumatic, Urinary tract infectious disease (5.7% ) Reproductive: Necrotizing fasciitis, Perineum |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/saxagliptin-and-dapagliflozin-drug-information)                                                                                                                                                                                                                                                                                                                  |

